SPONSOR
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Schizophrenia.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
How many clinical trials has CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Schizophrenia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. research focus on?
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. clinical trials span Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Schizophrenia. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. clinical trial?
To participate in a CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
NCT07421297 Phase 3
Recruiting
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT07493551
Recruiting
A Bioequivalence Study of PP3M in Patients With Schizophrenia
Schizophrenia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology